Advertisement
Screener

Rosetta Genomics Ltd. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

Rosetta Genomics Ltd. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

Rosetta Genomics Ltd. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$1.04 million for the 6-month period ending 2017-06-30, per its 6-K filed 2017-10-10.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-10-10

Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filedNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed
2017-06-30-$1.04M
6-K · filed 2017-10-10
2016-12-31-$11.96M
6-K · filed 2017-10-10
2016-06-30$306.00K
6-K · filed 2017-10-10
-$4.63M
6-K · filed 2016-09-26
2015-12-31-$16.29M
6-K · filed 2017-10-10
-$16.93M
20-F · filed 2016-03-23
2015-06-30-$8.39M
6-K · filed 2016-09-26
2014-12-31-$13.60M
6-K · filed 2017-10-10
2014-06-30-$7.56M
6-K · filed 2015-10-26
2013-12-31-$11.23M
6-K · filed 2016-12-08
2013-06-30-$5.22M
6-K · filed 2014-09-17
2012-12-31-$8.67M
20-F · filed 2015-03-16
2012-06-30-$4.90M
6-K · filed 2013-09-09
2011-12-31-$10.04M
20-F · filed 2014-03-31
2011-06-30-$5.23M
6-K · filed 2012-09-28
2010-12-31-$13.99M
20-F · filed 2013-03-22
2009-12-31-$12.23M
6-K · filed 2012-12-07